Sofinnova Investments, Inc. Protagonist Therapeutics, Inc Call Options Transaction History

Sofinnova Investments, Inc.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $25.52 $706,000 - $2.55 Million	-100,000 Reduced 50.0%	100,000 $791,000
Q1 2022 May 16, 2022	SELL	$23.34 - $36.08 $2.35 Million - $3.63 Million	-100,600 Reduced 33.47%	200,000 $4.74 Million
Q4 2021 Feb 14, 2022	BUY	$17.63 - $37.1 $5.3 Million - $11.2 Million	300,600 New	300,600 $10.3 Million

247

56.4M

76.3K

114K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $1.92B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.